Blue Phase Liquid Crystal Layer Contrast Ratio Optimization

The patent transitions from using nematic phase liquid crystals to blue phase liquid crystals. The blue phase is a distinct liquid crystal phase that occurs between the cholesteric phase and the isotropic phase. This phase transition enables the system to achieve both fast response speed and high contrast ratio by utilizing the unique properties of the blue phase, including its three-dimensional chiral structure that prevents light scattering and provides inherent optical isotropy.

The patent employs composite materials by combining blue phase liquid crystals with chiral dopants and polymer networks. The chiral dopants (such as R-811, S-811, or H711) are added to induce and stabilize the blue phase, while polymer networks are formed to further stabilize the phase and prevent light leakage. This composite approach achieves both fast response and high contrast ratio by leveraging the synergistic effects of multiple materials.

The patent optimizes the concentration of chiral dopants to be below the saturation solubility limit, specifically controlling the product of helical twisting power and concentration ([HTP]×c) to be 5.5 μm⁻¹ or more. This parameter optimization ensures that the blue phase is properly induced and stabilized without exceeding the solubility limit, thereby maintaining both high contrast ratio and phase stability. The patent also controls the Bragg diffraction wavelength to be 380 nm or less to prevent light leakage.

The patent uses polymer networks as an intermediary to stabilize the blue phase. The polymer network is formed within the liquid crystal matrix to provide structural support and prevent phase separation or precipitation of chiral dopants. This intermediary structure maintains phase stability even when chiral dopants are present at concentrations necessary for achieving high contrast ratio.

The patent controls the Bragg diffraction wavelength by optimizing the product of helical twisting power and concentration ([HTP]×c) to be 5.5 μm⁻¹ or more, which shifts the Bragg diffraction wavelength to 380 nm or less (into the ultraviolet range). This parameter control effectively prevents visible light leakage during black presentation while maintaining manufacturability through well-defined target values.

The patent replaces the need for precise mechanical control of liquid crystal alignment with an optical approach using chiral dopants and blue phase formation. Instead of relying on mechanical alignment procedures that require high precision, the system uses the inherent optical properties of the blue phase and chiral dopants to achieve the desired wavelength shift and contrast ratio improvement.